Suchen Sie nach Informationen zu Novartis-Unternehmensbüros? Folgen Sie den Links unten, um alle Informationen zu finden, die Sie benötigen, und mehr.
https://www.novartis.com/
Novartis receives priority review by US FDA and filing acceptance by EMA for Kymriah® to treat patients with relapsed or refractory follicular lymphoma. October 26, 2021. Media Release. Novartis delivers solid Q3 results, with strong growth in Innovative Medicines. Announces strategic review of Sandoz.
https://www.novartis.com/about/locations
Novartis Institutes for Biomed. Research Fabrikstrasse 2 Novartis Campus CH-4056 Basel. Switzerland. Phone: +41 61 324 1111. Fax: +41 61 324 8001. www.nibr.com . Pharmaceuticals. Basel. Novartis Pharma Services AG . Lichtstrasse 35 CH-4056 Basel. Switzerland. Phone: +41 61 324 00 00. Fax: +41 61 324 94 42. Novartis Pharma AG .
https://www.novartis.com/about/operations/global-biotech-cooperations/our-manufacturing-sites
Austria, Schaftenau Available services include: Drug substance mammalian manufacturing; Drug product fill & finish: syringes, cartridges, vials, autoinjectors, needle ...
https://www.novartis.com/investors
Investors. Creating value for our company, our shareholders and society. We aim for sustainable performance over time to benefit patients, employees, shareholders and society. Solid financial results and maintaining the trust of society underpin our ability to create value.
https://www.novartis.com/news/novartis-2021-financial-results
Novartis in Society Integrated Report 2021. The Novartis in Society Integrated Report covers our business, strategy and performance. It highlights progress against our five strategic priorities and describes how we create value for diverse stakeholders. View the report in English (PDF 7.7 MB) Access a digital and interactive version on the ...
https://www.novartis.com/news/novartis-financial-results-q2-2022
Novartis announced the company’s financial results for the second quarter and first half of 2022. Jul 19, 2022 Media Release. English (PDF 0.2 MB) | Deutsch (PDF 0.2 MB) | Français (PDF 0.2 MB) Interim financial report (PDF 0.5 MB) Investors. Watch the webcast 14:00 CEST | 13:00 BST | 08:00 EDT.
https://www.novartis.com/at-de/nachhaltigkeit/unternehmensethik
Alle Mitarbeitenden der Novartis Konzerngesellschaften sind verpflichtet, Ethik-, Risiko- und Compliance-Schulungen zu absolvieren. Unser globaler E-Training-Lehrplan vermittelt relevante Informationen, die es den Mitarbeitenden ermöglichen, im Rahmen ihrer Arbeit die richtigen Entscheidungen zu treffen und integer zu handeln.
https://www.novartis.com/at-de/stories/unternehmenskultur-bei-novartis
Neue Unternehmenskultur bei Novartis: mit Big Data zu neuen Arzneien. Als ersten konkreten Schritt des Kulturwechsels hat Novartis ein „Study Operation Center“ gegründet. Damit lässt sich täglich und in Echtzeit mit AI verfolgen, wie die gut 500 klinischen Studien des Unternehmens weltweit laufen. Mehr noch: Novartis will seine ...
https://www.my.novartis.com/about-us/corporate-responsibility/our-actions/patient-assistance-programs
In 2013, Novartis patient assistance programs in the US provided products worth USD 550 million to more than 96,000 patients in need. Novartis also supports the Partnership for Prescription Assistance , a single point of access to more than 475 public and private patient assistance programs in the US, including more than 180 programs offered by ...
https://www1.novartis.com/
The Novartis Commitment to Patients and Caregivers Novartis works with the patient community around the world to discover new ways to improve and extend people’s lives. Ukraine response. June 01, 2022. Novartis resumes business in …
Wir hoffen, dass Sie über die obigen Links alle notwendigen Informationen zu Novartis-Unternehmensbüros gefunden haben.
